Video

SWIFT PRIME Shows Strong Results for Endovascular Therapy Part 2

Author(s):

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

Jeffrey Saver, MD, FAHA, FAAN, from the Geffen School of Medicine at UCLA discussed the results of the study and the impact of the development of the therapy on the treatment of stroke at the International Stroke Conference in Nashville.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.